Previous 10 | Next 10 |
NEW YORK , Aug. 13, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists...
As the latest innovations are cropping up daily, the health sector is also enjoying those benefits. Several methods of testing and detecting various diseases are being developed day by day. For instance, identifying conditions like cancer at the early stages is growing as the day goes by, and ...
DarioHealth Corp. (DRIO) Q2 2020 Results Conference Call August 12, 2020 09:00 AM ET Company Participants Glenn Garmont - IR Erez Raphael - President and CEO Zvi Ben-David - CFO Rick Anderson - General Manager, North America Conference Call Participants Alex Nowak - Craig...
DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include the company’s announcement of two Remote...
DarioHealth (NASDAQ: DRIO ) : Q2 GAAP EPS of -$0.68 beats by $0.72 . Revenue of $1.79M (+8.5% Y/Y) beats by $0.24M . Shares +1.9% PM. Press Release More news on: DarioHealth Corp., Earnings news and commentary, Stocks on the move, Tech stocks news, ,
NEW YORK , Aug. 12, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter 2020 and provided a corporate and commercial update. "The COVID-19 pandemic has acc...
Several doping techniques among athletes are coming up due to new technology. One of the methods known as neuro-doping, is currently legal. The technique involves sending electric currents to one’s brain, hence facilitating rapid learning, improved coordination, and muscular strength. ...
DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital therapeutics market, was featured in a Fox Business segment on Friday titled, “Is telehealth the future of health care?” Dariohealth CEO Erez Raphael joined Fox’s Liz Claman to explain where he sees digital heal...
DarioHealth (NASDAQ: DRIO) , a pioneer in the global digital-therapeutics market, will release its second-quarter earnings on June 30, 2020, as well as host a 9 a.m. ET conference call and webcast on the same day. Hosted by CEO Erez Raphael, president and North America general manager Ri...
NEW YORK , Aug. 7, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020 , and ho...
News, Short Squeeze, Breakout and More Instantly...
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes PR Newswire Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solu...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, has announced that two employers, a national supply chain company and a regional education organization, have selected its integrated chronic condition management solutions. According to the announcement, beginning in the ...
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution PR Newswire Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp....